1. Kalka K, Merk H, Mukhtar H. Photodynamic therapy in dermatology. J Am Acad Dermatol 2000;42 (3): 389-413."
2. Tsoukas MM, Lin Gc, Lee Ms, Anderson RR, Kollias N. Predictive dosimetry for threshold phototoxicity in photodynamic therapy on normal skin: red wavelengths produce more extensive damage than blue at equal threshold doses. J Invest Dermatol 1997; 108:501-506.
3. Frazier CC. Photodynamic therapy in dermatology, hit J Dermatol 1996; 35 : 312-316.
4. Fritsch C, Goerz G, Ruzicka T. Photodynamic therapy in dermatology. Arch Dermatol 1998; 134:207-214.
5. Bissonette R, Lui H. Current status of pho SDÜ Tıp Fakültesi Dergisi 2000; 7(4); 37-45
todynamic therapy in dermatology. Dermatol Clin 1997; 15:507-519.
6. Lui H. Photodynamic therapy in dermatology. Arch Dermatol 1992; 128: 1631-1636.
7. Birol A, Kundakçı N. Fotodinamik tedavi. T Klin Dermatol 2000; 10 (3):222-228.
8. Özdemir F. Fotodinamik tedavi. Tiirkderm 1999; (3): 137-148.
9. HÖnigsmann H. Szeimes RM; Knobler R, Fitzppatrick TB, Pathak MA, Wolf K. Photoche-motherapy and photodynamic therapy in dermatology. In: Fitzpatrick TB, Eisen AZ, Wolf K, Freedberg IM, Austen Kf,eds. General medicine 5 th ed. New York: Mc Graw Hill, 1999: 2893¬6.
43
Fotodinamik Tedavi/Kesici, Yıldırım
10. Kurwa HA, Barlow RJ. The role of photodynamic therapy in dermatology. Clin Exp Dermatol 1999; 24: 143-148.
11. Ger seher S, Connelly J P. Beijersbergen GMJ, MacRobert A.J, Watt p, Rhodes LE. A quantitative assessment of protoporphyrin IX metabolism and phototoxicity in human skin following dose-controlled delivery of the prodrugs 5-Aminolevulinic acid and. 5-Aminolevulinic acid-n-pentylester.
12.
Ceylan C, Özdemir F, Erboz S, Kazandı A, Öz.ol A. Bazal Hücreli karsinomda topikal fotodinamik tedavi. Türkderm 1999; 33 (3): 153¬157.
13. Zeitouni NC, Shieh S, Oseroff AR. Laser and photodynamic therapy in the management of cutaneous malignancies. Dermatol Clin 2001;19; 328-339.
14. Erboz
S.
Dermatolojide fotodinamik tedavi. Dermatoljide Gelişmeler-4. Ed. Aydemir EH, Onsun N. İstanbul, 1999, Gizben tanıtı ve organizasyon ltd şti; 168-178.
15. Svanberg K, Andersson T, Killander D, Wang I, Stenranı U, Andersson-Engels, Berg R, Johansson J, Svanberg S. Photodynamic therapy of non -melanoma malignant tumours of the skin using topical d-aminolevulinic acid sensitization and laser irradiation. Br J Dermatol 1994; 130: 743-751.
16. Markham T, Collins P. Topical 5-Aminolevu-linic acid, photodynamic therapy for extensive scalp actinic keratoses. Br J Dermatol 2001; 145: 502-504.
17. Itoh Y, Ninomiya Y, Henta T, Taj ima. S, İshi-bashi A. Topical ^Aminolevulinic acid-based photodynamic therapy for Japanese actinic keratoses. J Dermatol 2000; 27: 513-518.
18. Szeimes RM, Kar re r S, Sauerwald A, Landt-haler M. Photodynamic therapy with topical of 5-Aminolevulinic acid in the treatment of actinic keratoses an initial clinical study. Dermatology 1996; 192: 246-251.
19. Szeimes RM, Kar re r S, Sauerwald A. Photodynamic therapy with topical application of 5-Aminolevulinic acid in the treatment of actinic keratoses: an initial clinical study. J Am Acad Dermatol 1997; 36(1)
20. Erboz. S, Ceylan C, Özdemir F, Kazandı A, Özol A. Solar keratozda fotodinamik tedavi. Türkderm 1999: 33 (2); 75-78.
21. Jeff es EW, McCullough JL, Weinstein GD, Fergin. PE, Nelson JS, Shull TF, Simpson KR, Bukaty LM. Photodynamic therapy of actinic keratoses with topical 5-Aminolevulinic acid. Arch Dermatol 1997; 133: 727-733.
22. Kurwa HA, Yong-Gee SA, Seed PT, Markey AC, Barlow RJ,. A randomized paired comparison of photodynamic therapy and 5-fluorouracil
SDÜ Tıp Fakültesi Dergisi 2000; 7(4): 37-45
in the treatment of actinic keratoses. J Am Acad Dermatol 1999; 41 (3): 414-418.
23. Stender 1M, Wulf HC. Photodynamic therapy with 5-Aminolevulinic acid in the treatment of actinic cheilitis. Br J Dermatol 1996; 135: 454-456.
24. Stables GI, Stringer MR, Robinson DJ, Ash DV. Large patches ofBowen's disease treated by topical aminolevulinic acid photodynamic therapy. Br J Dermatol 1997; 136: 957-960.
25. Stables GI, Stringer MR, Robinson DJ, Ash DV. Erythroplasia of queyrat treated by topical aminolevulinic acid photodynamic therapy. Br J Dermatol 1999; 140: 514-517.
26. Itoh Y, Henta T, Ninomiya Y, Tajima S, Islı i bashi A. Repeated 5-Aminolevulinic acid-based photodynamic therapy following electro-cu-rettage for pigmented basal cell carcinoma. J Dermatol 2000; 27: 10-/5.
27. Wilson BD, Mang TS, Stoll H, Jones C, Cooper M, Dougherty TJ. Photodynamic therapy for the treatment of basal cell carcinoma. Arch Dermatol 1992; 128. 1597-1601.
28. Wang I, Bendsoe N, Klinteberg CAE Enej-der AM, Andersson-Engels S, Svanberg S, Svanberg K. Photodynamic therapy vs. cryosurgery of basal cell carcinomas: results of a phase III clinical trial. Br J Dermatol 2001; 144: 832¬840.
29. Wolf P, Rieger E, Kerl H. Topical photodynamic therapy with endogenous porphyrins after application of 5-aminolevulinic acid. J Am Acad Dermatol 1993;1:17-21.
30. Gross DJ, Waner M, Schosser RH, D in e hart Sm. Squamous cell carcinoma of the lower lip involving a large cutaneous surface. Arch Dermatol 1990; 126: 1148-1150.
31. Gür AR. Mikozis fungoideste tanı ve tedavi. XII.Prof.Dr.A.Lütfü TATsimpozyumu. Ed.Erdem C. Ankara, 1995, Ayrıntı Ofset: 15-26.
32. Wolf P, Fink-Puches R, Cerroni L, Kerl H. Photodynamic therapy for mycosis fungoides after topical photosensitization with 5-aminole-vulinic acid. J Am Acad Dermatol 1994; 31: 678-680.
33. Stringer MR, Collins P, Robinson DJ, Stables GI, Sheehan-Dare RA. The accumulation of protoporphyrin IX in plaque psoriasis after topical application of 5-aminolevulinic acid indicates a potential for superficial photodynamic therapy. J Invest Dermatol 1996; 107: 76-81.
34. Collins P, Robinson DJ, Stringer MR, Stables GI, Sheehan-Dare RA. The variable response of plaque psoriasis after a single treatment with 5-aminolevulinic acid photodynamic therapy. Br J Dermatol 1997; 137: 743-749.
35. Fehr MK, Chapman FC, Krasieva T, Tro/n-berg Bj, McCullough JL, Bems MW, Tadir Y.
44
Fotodinamik Tedavi/Kesici, Yıldırım.
Selective photosen.sitiz.er distribution in. vulvar condyloma acuminatum after topical application of 5-Aminolevulinic acid. J Am Acad Dermatol 1996 ; 174(39)
36. Kar re r S, Szeimes RM, Abels C, Wloizke, U, Stolz W, iMiidthaler M. Epidermodysplasia verruciformis treated using topical 5-aminolevulinic acid photodynamic therapy. Br J Dermatol 1999; 140; 935-938.
37. Bissonette R, Shapiro J, Zeng H, Mclean DI, Lui H. Topical photodynamic therapy with 5-aminolevulinic acid does not induce hair reg-rowth in patients with extensive alopecia areata. Br J Dermatol 2000; 143: 1032-1035.
38. Itoh Y, Ninomiya Y, Tajima S, ishibashi A. Photodynamic therapy of acne vulgaris with topical d-aminolevulinic acid and incohorent light in Japanese patients. Br J Dermatol 2001; 144: 575-579.
39. Itoh Y, Ninomiya Y, Tajima S, İshibashi A. Photodynamic therapy for acne vulgaris with topical 5-aminolevulinic acid. Arch Dermatol 2000; 136: 1093-1095.
40. Hongcharu W, Taylor Cr, Chang Y, Aghassi D, Suthamjariya K, Andersson RR. Topical ALA-photodynamic therapy for the treatment of acne vulgaris. J Invest Dermatol 2000; 15 (2): 183-192.
41. Henta T, Itoh Y, Kobay as hi M, Ninomiya Y, ishibashi A. Photodynamic therapy for inoperable vulval Pa get's disease using d-aminolevulinic acid: successful mangement of a large skin lesion. Br J Dermatol 1999; 141; 347-349.
42. Diericks CC, Golden/iersh M, Dwyer P, Stratigos A, Mihm M, Anderson R. Photodynamic therapy for nevus sebaceus with d-aminolevulinic acid. Arch Dermatol 1999; 135: 637-638.
43. Wolf P, Fink-Puches R, Reimann-Weber, A.Kerl H. Development of malignant melanoma after repeated topical photodynamic therapy with 5-aminolevulinic. acidat the exoposed site. Dermatology 1997; 194: 53-54.
Thank you for copying data from http://www.arastirmax.com